Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 Apr;18(4):290-4.
doi: 10.1136/gut.18.4.290.

Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract

Clinical Trial

Enzymatic and morphometric evidence for Crohn's disease as a diffuse lesion of the gastrointestinal tract

W T Dunne et al. Gut. 1977 Apr.

Abstract

Intestinal disaccharidase and dipeptidase activities were measured in mucosal biopsies from the proximal jejunum in 20 patients with Crohn's disease apparently confined to the distal ileum or large bowel, 14 patients with ulcerative colitis, and 14 healthy volunteers who acted as controls. The dissecting microscopy and histological appearance of the biopsies were normal (Gd 0-1) except for two which showed grade 2 changes. tbiopsy morphometry showed a reduction of jejunal mucosal surface area and an increase in mucosal volume in patients with Chron's disease when compared with the other two groups. The mucosal enzymes studies demonstrated that patients with Crohn's disease had a significant reduction in brush-border enzymes (disaccharidase) but no change in cytoplasmic enzyme activity (dipeptidases). The enzyme levels in patients with ulcerative colitis did not differ from the healthy controls. The reduction of brush-border enzymes with normal cytoplasmic enzymes in the presence of abnormal morphometry is further evidence of the concept of Crohn's disease as a diffuse lesion of the gastrointestinal tract. It also suggests that there is either specific damage to the microvilli or some other abnormality such as impairment of enzyme synthesis.

PubMed Disclaimer

References

    1. Lancet. 1964 Jul 25;2(7352):185-6 - PubMed
    1. Am J Dig Dis. 1962 Aug;7:744-59 - PubMed
    1. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
    1. Lancet. 1976 Feb 7;1(7954):275-8 - PubMed
    1. J Clin Pathol. 1972 Mar;25(3):243-6 - PubMed

Publication types

LinkOut - more resources